Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun 1;138(6):660-670.
doi: 10.1001/jamaophthalmol.2020.1120.

Outcomes of Limbal Stem Cell Transplant: A Meta-analysis

Affiliations
Review

Outcomes of Limbal Stem Cell Transplant: A Meta-analysis

Qihua Le et al. JAMA Ophthalmol. .

Abstract

Importance: Limbal stem cell transplant (LSCT) can be categorized as direct autologous limbal transplant (AULT), direct allogenic limbal transplant (ALLT), cultivated autologous limbal stem cells transplant (cAULT), and cultivated allogenic limbal stem cells transplant (cALLT). To our knowledge, there is no study directly comparing the outcomes and complications of these procedures.

Objective: To evaluate the outcomes of different LSCT procedures.

Data source: We searched PubMed, EMBASE, Web of Science, and Cochrane without language filter for peer-reviewed articles about LSCT. The latest search was performed on June 30, 2019.

Study selection: Clinical studies with the outcome of at least 20 eyes after LSCT were included. Animal studies and studies of other surgical interventions were excluded.

Data extraction and synthesis: Two reviewers independently abstracted the data from each study. Heterogeneity was evaluated with the I2 statistic, and a meta-analysis was performed using the random-effects model.

Main outcomes and measures: Outcome measures included the improvement of ocular surface, visual acuity (VA), and adverse events of recipient eyes and donor eyes.

Results: Forty studies (2202 eyes) with a mean (SD) follow-up of 31.3 (20.9) months met the inclusion criteria. The mean (SD) age of study participants was 38.4 (13.1) years, and men accounted for 74%. The number of eyes that underwent AULT, ALLT, cAULT, and cALLT were 505, 742, 771, and 184, respectively. Improvement of the ocular surface was achieved in 74.5% of all eyes, 85.7% of eyes after AULT (95% CI, 79.5%-90.3%), 84.7% after cAULT (95% CI, 77.2%-90.0%), 57.8% after ALLT (95% CI, 49.0%-66.1%), and 63.2% after cALLT (95% CI, 49.3%-75.2%). Autologous limbal transplantation resulted in a greater VA improvement rate (76%) than did the other 3 procedures (cAULT: 56.4%; ALLT: 52.3%; cALLT: 43.3%; all P < .001). The most common adverse events in all recipient eyes were recurrent/persistent epithelial erosion (10.5%; 95% CI, 7.2%-23.3%) and elevated intraocular pressure (intraocular pressure, 1.7%; 95% CI, 0.5%-7.8%). Patients who underwent ALLT had the highest rate of recurrent epithelial erosion (27.8%; 95% CI, 17.1%-41.9%) and intraocular pressure elevation (6.3%; 95% CI, 1.8%-19.4%).

Conclusions and relevance: These findings suggest LSCT can improve or stabilize the corneal surface with a low rate of severe ocular complications and that autologous LSCT may have a higher success rate and fewer complications than allogenic LSCT.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Deng is a consultant for W. L. Gore & Associates, F-Prime Partners, Dompe US, and Kowa Research Institute, Inc on subjects that are unrelated and reports grants from the National Eye Institute and grants from California Institute for Regenerative Medicine during the conduct of the study; in addition, Dr Deng had a patent to EP3554487A1 issued and a patent to US2016/0376555A1 pending. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. Forest Plots for Success Rate of Limbal Stem Cell Transplant
The highest success rates were achieved after direct autologous limbal transplant (AULT) followed by cultivated autologous limbal stem cells transplant (cAULT). The success rates after direct allogenic limbal transplant (ALLT) and cultivated allogenic limbal stem cells transplant (cALLT) were lower than that after AULT.
Figure 2.
Figure 2.. Forest Plots for Improvement Rate of Limbal Stem Cell Transplantation
The surface improvement rates of after direct autologous limbal transplant (AULT) and autologous limbal stem cells transplant (cAULT) were similar to the success rates shown in Figure 1.
Figure 3.
Figure 3.. Forest Plots for Failure Rate of Limbal Stem Cell Transplantation
The failure rate was significantly higher for direct allogenic limbal transplant (ALLT) and cultivated allogenic limbal stem cells transplant (cALLT) than for direct autologous limbal transplant (AULT)and cultivated autologous limbal transplant (cAULT).

References

    1. Deng SX, Borderie V, Chan CC, et al. ; and The International Limbal Stem Cell Deficiency Working Group . Global consensus on definition, classification, diagnosis, and staging of limbal stem cell deficiency. Cornea. 2019;38(3):364-375. doi:10.1097/ICO.0000000000001820 - DOI - PMC - PubMed
    1. Kim BY, Riaz KM, Bakhtiari P, et al. . Medically reversible limbal stem cell disease: clinical features and management strategies. Ophthalmology. 2014;121(10):2053-2058. doi:10.1016/j.ophtha.2014.04.025 - DOI - PMC - PubMed
    1. Sangwan VS, Basu S, Vemuganti GK, et al. . Clinical outcomes of xeno-free autologous cultivated limbal epithelial transplantation: a 10-year study. Br J Ophthalmol. 2011;95(11):1525-1529. doi:10.1136/bjophthalmol-2011-300352 - DOI - PubMed
    1. Basu S, Sureka SP, Shanbhag SS, Kethiri AR, Singh V, Sangwan VS. Simple limbal epithelial transplantation: long-term clinical outcomes in 125 cases of unilateral chronic ocular surface burns. Ophthalmology. 2016;123(5):1000-1010. doi:10.1016/j.ophtha.2015.12.042 - DOI - PubMed
    1. Zhao Y, Ma L. Systematic review and meta-analysis on transplantation of ex vivo cultivated limbal epithelial stem cell on amniotic membrane in limbal stem cell deficiency. Cornea. 2015;34(5):592-600. doi:10.1097/ICO.0000000000000398 - DOI - PubMed